KR20220108628A - Food Composition For Improving Skin Elasticity Or Moisture - Google Patents
Food Composition For Improving Skin Elasticity Or Moisture Download PDFInfo
- Publication number
- KR20220108628A KR20220108628A KR1020210011840A KR20210011840A KR20220108628A KR 20220108628 A KR20220108628 A KR 20220108628A KR 1020210011840 A KR1020210011840 A KR 1020210011840A KR 20210011840 A KR20210011840 A KR 20210011840A KR 20220108628 A KR20220108628 A KR 20220108628A
- Authority
- KR
- South Korea
- Prior art keywords
- ginseng
- food composition
- glue
- present
- weight
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 71
- 235000013305 food Nutrition 0.000 title claims abstract description 52
- 230000037394 skin elasticity Effects 0.000 title claims abstract description 26
- 239000003292 glue Substances 0.000 claims abstract description 55
- 235000020710 ginseng extract Nutrition 0.000 claims abstract description 35
- 239000004480 active ingredient Substances 0.000 claims abstract description 8
- 241000208340 Araliaceae Species 0.000 claims description 41
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 40
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 40
- 235000008434 ginseng Nutrition 0.000 claims description 40
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 13
- 241000283074 Equus asinus Species 0.000 claims description 6
- 239000011782 vitamin Substances 0.000 claims description 4
- 229940088594 vitamin Drugs 0.000 claims description 4
- 235000013343 vitamin Nutrition 0.000 claims description 4
- 229930003231 vitamin Natural products 0.000 claims description 4
- 235000013361 beverage Nutrition 0.000 claims description 3
- 235000013334 alcoholic beverage Nutrition 0.000 claims description 2
- 235000013616 tea Nutrition 0.000 claims description 2
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 28
- 239000000284 extract Substances 0.000 abstract description 17
- 230000003020 moisturizing effect Effects 0.000 abstract description 13
- 230000037406 food intake Effects 0.000 abstract description 9
- 230000036559 skin health Effects 0.000 abstract description 4
- 239000002537 cosmetic Substances 0.000 abstract description 3
- 230000036074 healthy skin Effects 0.000 abstract description 3
- 235000002789 Panax ginseng Nutrition 0.000 description 22
- 238000002360 preparation method Methods 0.000 description 20
- 239000012141 concentrate Substances 0.000 description 18
- 235000008504 concentrate Nutrition 0.000 description 17
- 210000003491 skin Anatomy 0.000 description 16
- 238000000605 extraction Methods 0.000 description 15
- 239000008194 pharmaceutical composition Substances 0.000 description 14
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 230000006872 improvement Effects 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 230000003796 beauty Effects 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000013355 food flavoring agent Nutrition 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000003960 organic solvent Substances 0.000 description 6
- 239000000546 pharmaceutical excipient Substances 0.000 description 6
- 239000002775 capsule Substances 0.000 description 5
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 108010050808 Procollagen Proteins 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 230000037333 procollagen synthesis Effects 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 229930091371 Fructose Natural products 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000007884 disintegrant Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000015203 fruit juice Nutrition 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000001766 physiological effect Effects 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 239000007901 soft capsule Substances 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 238000010025 steaming Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 229940124597 therapeutic agent Drugs 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 241000283086 Equidae Species 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 238000001793 Wilcoxon signed-rank test Methods 0.000 description 2
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 125000003158 alcohol group Chemical group 0.000 description 2
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N alpha-methyl toluene Natural products CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 2
- 230000002785 anti-thrombosis Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 108010052008 colla corii asini Proteins 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 210000000245 forearm Anatomy 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000007902 hard capsule Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- JQOAQUXIUNVRQW-UHFFFAOYSA-N hexane Chemical compound CCCCCC.CCCCCC JQOAQUXIUNVRQW-UHFFFAOYSA-N 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 230000037067 skin hydration Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 235000015192 vegetable juice Nutrition 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- AGBCLJAHARWNLA-DQUQINEDSA-N Ginsenoside RG2 Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]3C(C)(C)[C@@H](O)CC[C@]3(C)[C@@H]3[C@@]([C@@]4(CC[C@@H]([C@H]4[C@H](O)C3)[C@@](C)(O)CCC=C(C)C)C)(C)C2)O[C@H](CO)[C@@H](O)[C@@H]1O AGBCLJAHARWNLA-DQUQINEDSA-N 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 235000002791 Panax Nutrition 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- FYGDTMLNYKFZSV-DZOUCCHMSA-N alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-DZOUCCHMSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- -1 and the like Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 235000015197 apple juice Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 235000015190 carrot juice Nutrition 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000000748 compression moulding Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 239000013583 drug formulation Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 208000016253 exhaustion Diseases 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 235000019674 grape juice Nutrition 0.000 description 1
- 208000024798 heartburn Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 238000001794 hormone therapy Methods 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 239000000367 immunologic factor Substances 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000001626 skin fibroblast Anatomy 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000015193 tomato juice Nutrition 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/275—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of animal origin, e.g. chitin
- A23L29/281—Proteins, e.g. gelatin or collagen
- A23L29/284—Gelatin; Collagen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2124—Ginseng
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/54—Proteins
- A23V2250/542—Animal Protein
- A23V2250/5432—Gelatine
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Zoology (AREA)
- Dispersion Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
Abstract
Description
본 발명은 피부 탄력 또는 보습 개선용 식품 조성물에 관한 것이다.The present invention relates to a food composition for improving skin elasticity or moisture.
피부는 우리 몸의 가장 큰 기관으로서 전체 우리 몸 부피의 약 16%를 차지하고, 외부 환경과 직접 접해 있으면서, 몸 안으로 침입하려는 치명적인 많은 유해 인자들, 외부 자극으로부터 인체를 보호하는 기능을 한다. 피부는 가장 바깥층인 각질층(Cornified layer)을 포함한 표피(Epidermis), 그 아래 진피 (Dermis), 가장 아래 피하지방층(Hypodermis)으로 구성되어 있다. As the largest organ of our body, the skin occupies about 16% of the total volume of our body, and while in direct contact with the external environment, it functions to protect the human body from many harmful factors and external stimuli that try to invade the body. The skin consists of the epidermis including the cornified layer, which is the outermost layer, the dermis below it, and the hypodermis at the bottom.
이너뷰티(Inner Beauty)란 '이너(Inner)'와 아름다움을 의미하는 '뷰티(Beauty)'의 합성어로 인체 내부로부터 건강한 피부를 가꾼다는 뜻으로, 아름답기를 원하는 사람들의 욕망이 커지면서 먹는 화장품이라 불리는 이너뷰티에 대한 관심이 많아지고 있다. 국내 이너뷰티 시장 규모는 2011년 500억에서 2019년 5000억으로 8년만에 10배 규모로 성장하였다. 이러한 식품 섭취를 통해 피부의 보습, 탄력, 착색에 관한 효능을 기대하는 제품의 시장의 지속적인 확대가 기대된다.Inner Beauty is a compound word of 'Inner' and 'Beauty', which means beauty. It means to take care of healthy skin from the inside of the human body. Interest in inner beauty is growing. The size of the domestic inner beauty market has grown tenfold in eight years from 50 billion won in 2011 to 500 billion won in 2019. It is expected that the market for products that are expected to be effective in moisturizing, elasticity, and pigmentation of the skin through consumption of these foods will continue to expand.
대부분의 피부 보습 화장품이 각질층의 수분 및 유효성분 흡수에 집중되어 있는 반면, 이너뷰티 소재는 섭취된 후 소화기관 및 혈관을 통해 체내로 전달되어 피부건강 환경을 조성함으로써 각질뿐만 아니라 표피층 전체, 및 진피층의 피부 조직에 작용하여 보습 및 탄력 개선 등의 효과를 나타낸다. 이러한 이너뷰티 소재에 대한 연구 및 개발이 지속적으로 이루어지고 있다. While most skin moisturizing cosmetics concentrate on the absorption of moisture and active ingredients in the stratum corneum, inner beauty materials are delivered to the body through the digestive system and blood vessels after ingestion to create a healthy skin environment, thereby creating a healthy environment for skin as well as the entire epidermis and dermis layer. It acts on the skin tissue of the skin and shows effects such as moisturizing and elasticity improvement. Research and development of these inner beauty materials are continuously being made.
인삼은 식물 분류학상으로 오갈피나무과(Araliaceae)의 인삼속(Panax)에 속하는 다년생 음지성 초본식물로서 오래 전부터 한방에서 중요한 약재로 사용되었다. 인삼의 사포닌은 항암 작용, 항산화 작용, 동맥경화 및 고혈압 예방, 간기능 개선, 항피로, 항스트레스 작용, 노화 방지, 두뇌 활동 촉진, 항염 활성, 알레르기성 질환 치료 및 단백질 합성 능력의 촉진 등의 생리 활성이 있으며, 고려 홍삼은 항산화, 혈압 강하, 알코올성 고지혈증 개선, 혈당 강하 작용 등의 우수한 생리활성을 보유하는 것으로 알려져 있다.Ginseng is a perennial, shady herbaceous plant belonging to the genus Panax of the Araliaceae family, and has been used as an important medicinal material in oriental medicine for a long time. The saponins of ginseng have anticancer activity, antioxidant activity, prevention of arteriosclerosis and high blood pressure, improvement of liver function, anti-fatigue, anti-stress activity, anti-aging, brain activity promotion, anti-inflammatory activity, treatment of allergic diseases, and promotion of protein synthesis ability. It is active, and Korean red ginseng is known to have excellent physiological activities such as antioxidant, blood pressure lowering, alcoholic hyperlipidemia improvement, and blood sugar lowering action.
인삼은 일반적으로 가공 방법에 따라 백삼과 홍삼으로 구분되며, 백삼은 밭에서 채굴한 가공되지 아니한 인삼 즉, 수삼을 그대로 건조한 것을 지칭하며 홍삼은 수삼을 증숙하여 건조 가공한 것으로 제조과정에서 사포닌 변형과 아미노산 변화 등 여러 화학적인 변화가 수반된다. 홍삼은 제조 과정에서 가해지는 열에 의해 인삼에 존재하지 않는 진세노사이드 Rg2, Rg3, Rh1, Rh2 등의 사포닌 성분이 생성되며, 홍삼 특유의 유효 성분은 암 예방 작용, 암세포 성장억제 작용, 혈압 강하 작용, 뇌신경세포 보호 및 학습 능력 개선 작용, 항혈전 작용, 항산화 작용 등이 우수하여 탁월한 약리 효능을 기대할 수 있다.Ginseng is generally divided into white ginseng and red ginseng according to the processing method. White ginseng refers to unprocessed ginseng mined in the field, that is, fresh ginseng as it is, and red ginseng is steamed and dried and processed by steaming fresh ginseng. Numerous chemical changes, such as amino acid changes, are involved. Red ginseng produces saponin components such as ginsenosides Rg2, Rg3, Rh1, and Rh2 that are not present in ginseng due to the heat applied during the manufacturing process. Excellent pharmacological efficacy can be expected as it has excellent anti-thrombotic, anti-oxidative, and anti-thrombotic properties, improving brain nerve cells and learning ability.
아교(Colla Corii Asini)는 동물 유래의 가죽 또는 뼈를 물에서 가열하여 추출된 추출물을 응고시키는 방법으로 제조한다. 아교는 주성분이 젤라틴(gelatin)으로서 상온에서는 보통 흑갈색의 고체이고, 물을 가하면 콜로이드가 되며, 가열하면 졸 상태가 된다. Glue (Colla Corii Asini) is prepared by heating animal-derived hides or bones in water to coagulate the extracted extract. The main component of glue is gelatin, and at room temperature, it is usually a blackish-brown solid. When water is added, it becomes a colloid, and when heated, it becomes a sol state.
예로부터 아교는 민간에서 널리 사용되었는데, 소 또는 말 유래의 아교는 접착력을 가져 목재, 종이, 천 등의 접착제로 사용되었고, 당나귀 유래의 아교는 맛이 달고 신맛이 조금 있기는 하나 독성이 없고, 보혈자음(補血滋陰), 윤조(潤燥), 지혈(止血) 등의 생리효과가 뛰어나다고 알려져, 혈허위황(血虛萎黃), 현훈심계(眩暈心悸), 기위무력(肌無力), 심번불면(心煩不眠), 허풍내동(虛風內動), 폐조해수(肺燥咳嗽), 노수객혈(勞嗽喀血), 토혈뇨혈(吐血尿血), 변혈붕루(便血崩漏), 임신태루(妊娠胎漏)에 약재로서 쓰였다.Glue has been widely used in the private sector since ancient times. Glue derived from cattle or horses has adhesive strength and was used as an adhesive for wood, paper, and cloth. It is known to have excellent physiological effects such as bohyeol consonants, lubrication, and hemostasis, and it is known for its excellent physiological effects, such as hyeol-heo-wi-hwang (血虛) Insomnia, heartburn, insomnia, flatulence, seawater exhaustion, hemoptysis, hematemesis in urine, discoloration , was used as a medicine for pregnancy taeru (妊娠胎漏).
본 발명자들은 피부의 탄력 또는 보습 개선 효과를 나타낼 수 있는 식품 조성물에 대한 연구를 계속하던 중, 인삼 추출물과 아교를 이용하여 근본적으로 피부 건강을 개선할 수 있는 가능성을 발견하고 본 발명을 완성하였다.The present inventors have completed the present invention by discovering the possibility of fundamentally improving skin health by using ginseng extract and glue while continuing research on a food composition that can exhibit the effect of improving skin elasticity or moisture.
본 발명은 피부의 탄력 또는 보습 개선 효과를 나타낼 수 있는 천연유래 추출물을 포함하는 식품 조성물을 제공하는 것을 목적으로 한다.An object of the present invention is to provide a food composition comprising a naturally-derived extract that can exhibit an effect of improving skin elasticity or moisture.
본 발명의 일 양태는 인삼 추출물; 및 아교;를 유효성분으로 포함하는 피부의 탄력 또는 보습 개선용 식품 조성물을 제공한다.One aspect of the present invention is a ginseng extract; and glue; as an active ingredient, providing a food composition for improving skin elasticity or moisture.
본 발명의 식품 조성물은 천연유래 추출물인 인삼 추출물 및 아교를 포함함으로써 섭취를 통해 피부의 탄력 또는 보습 개선 효과를 나타낼 수 있다. 본 발명의 식품 조성물은 유효성분을 체내로 전달하여 피부 건강 환경을 조성함으로써 탄력 또는 보습 개선 효과를 나타내는 것이므로, 바르는 화장료 조성물에 비해 근본적으로 피부 건강을 개선하는 효과가 있다.The food composition of the present invention can exhibit the effect of improving skin elasticity or moisture through ingestion by including ginseng extract and glue, which are naturally derived extracts. Since the food composition of the present invention exhibits an effect of improving elasticity or moisture by delivering an active ingredient into the body to create a skin health environment, it has an effect of fundamentally improving skin health compared to a cosmetic composition to be applied.
도 1은 인삼 추출물 및 아교의 복합물의 프로콜라겐 합성 효과를 나타낸다.
도 2는 본 발명의 식품 조성물을 8주 동안 섭취한 후 피부 보습력 개선 효과를 나타낸다.
도 3은 본 발명의 식품 조성물을 8주 동안 섭취한 후 피부 탄력 개선 효과를 나타낸다. 1 shows the procollagen synthesis effect of a complex of ginseng extract and glue.
Figure 2 shows the effect of improving skin moisturizing power after ingesting the food composition of the present invention for 8 weeks.
3 shows the skin elasticity improvement effect after ingesting the food composition of the present invention for 8 weeks.
이하, 본 발명에 대한 이해를 돕기 위하여 본 발명을 더욱 상세하게 설명한다. Hereinafter, the present invention will be described in more detail to help the understanding of the present invention.
본 명세서 및 청구범위에서 사용된 용어나 단어는 통상적이거나 사전적인 의미로 한정해서 해석되어서는 아니 되며, 발명자는 그 자신의 발명을 가장 최선의 방법으로 설명하기 위해 용어의 개념을 적절하게 정의할 수 있다는 원칙에 입각하여 본 발명의 기술적 사상에 부합하는 의미와 개념으로 해석되어야만 한다.The terms or words used in the present specification and claims should not be construed as being limited to their ordinary or dictionary meanings, and the inventor may properly define the concept of the term in order to best describe his invention. Based on the principle that there is, it should be interpreted as meaning and concept consistent with the technical idea of the present invention.
1. 피부의 탄력 또는 보습 개선용 식품 조성물1. Food composition for improving skin elasticity or moisture
본 발명의 일 양태는 인삼 추출물; 및 아교;를 유효성분으로 포함하는 피부의 탄력 또는 보습 개선용 식품 조성물을 제공한다.One aspect of the present invention is a ginseng extract; and glue; as an active ingredient, providing a food composition for improving skin elasticity or moisture.
본 발명에서 일컫는 '추출물'은 원료로부터 임의의 방법으로 추출된 물질을 의미하며, 이렇게 추출된 추출액, 이로부터 얻을 수 있는 농축액, 상기 농축액의 건조물 및 분말을 제한 없이 모두 포함하는 의미로 사용된다.As used herein, the term 'extract' refers to a material extracted from a raw material by an arbitrary method, and is used in the meaning of including, without limitation, the extracted extract, the concentrate obtainable therefrom, the dried product and the powder of the concentrate.
본 발명에서 '인삼 추출물'은 인삼 또는 이의 건조물로부터 추출하여 얻을 수 있으며, 상기 인삼은 재배한 것 또는 시판되는 것 등을 제한 없이 사용할 수 있다. 상기 인삼은 인삼 산업법 상의 여러가지 명칭을 모두 포함하는 의미로 사용될 수 있고, 다양하게 가공된 것을 포함하며, 예를 들면 수삼, 미삼, 흑삼, 산삼, 장뇌삼, 산양삼, 백삼, 태극삼, 호정화 인삼, 효소 처리된 미삼, 발효 인삼, 홍삼 및 발효 홍삼으로 이루어지는 군으로부터 선택되는 적어도 어느 하나일 수 있으며, 이에 한정되지 않는다. 수삼은 원형을 유지한 생인삼을 말하고, 미삼은 인삼의 가는 뿌리를 말한다. 홍삼은 생인삼을 쪄서 익혀 건조한 것으로 건조 과정에서 갈변 반응이 일어나 담황갈색 내지 적갈색을 띄는 것이다. 흑삼은 홍삼을 더 여러 번 찌고 건조하여 흑색으로 변화한 인삼을 말한다. 산삼은 자생 인삼을 말하며, 장뇌삼은 심어서 기른 산삼을 말한다. 산양삼은 산간의 삼림 하에서 인위적으로 종자나 묘삼을 파종 이식하여 재배한 인삼이다.In the present invention, 'ginseng extract' can be obtained by extracting ginseng or a dried product thereof, and the ginseng cultivated or commercially available can be used without limitation. The ginseng can be used in a sense that includes all of the various names in the ginseng industry law, and includes variously processed ones, for example, fresh ginseng, fine ginseng, black ginseng, wild ginseng, camphor ginseng, wild ginseng, white ginseng, Taegeuk ginseng, hojeonghwa ginseng, It may be at least one selected from the group consisting of enzyme-treated raw ginseng, fermented ginseng, red ginseng, and fermented red ginseng, but is not limited thereto. Fresh ginseng refers to raw ginseng that maintains its original shape, and fine ginseng refers to the fine root of ginseng. Red ginseng is made by steaming raw ginseng and drying it. During the drying process, a browning reaction takes place, resulting in a pale yellowish-brown to reddish-brown color. Black ginseng refers to ginseng changed to black by steaming and drying red ginseng several times. Wild ginseng refers to native ginseng, and Jangnoe ginseng refers to planted and grown wild ginseng. Wild ginseng is ginseng cultivated by artificially sowing and transplanting seeds or seedlings under mountainous forests.
상기 인삼으로부터 추출물을 수득할 때, 추출 방법으로는 용매 추출법, 초음파 추출법, 여과법 및 환류 추출법 등 종래 알려진 통상적인 추출 방법을 모두 사용할 수 있으며, 바람직하게는 용매 추출법이나 환류 추출법을 이용함으로써 제조할 수 있다. 상기 추출 과정은 수회 반복할 수 있다. 상기 추출물은 추출물을 추가적으로 분획하여 얻은 분획물도 포함한다.When obtaining the extract from the ginseng, as the extraction method, all conventional known extraction methods such as solvent extraction, ultrasonic extraction, filtration, and reflux extraction may be used, and preferably by using a solvent extraction method or reflux extraction method. have. The extraction process may be repeated several times. The extract also includes a fraction obtained by further fractionating the extract.
상기 인삼으로부터 추출물을 수득할 때, 물, 유기용매, 초임계 유체 및 이들의 혼합물로 이루어진 군으로부터 선택되는 1종 이상을 추출용매로 사용할 수 있다. 상기 유기용매는 알코올, 바람직하게는 C1-C4의 저급 알코올, 헥산(n-헥산), 에테르, 글리세롤, 프로필렌글리콜, 부틸렌글리콜, 에틸아세테이트, 메틸아세테이트, 디클로로메탄, 클로로포름, 에틸아세테이트, 벤젠 및 이들의 혼합용매로 이루어지는 군으로부터 선택되는 어느 하나일 수 있고, 바람직하게는 물일 수 있다. 물 및 유기용매의 혼합물을 추출 용매로 사용하는 경우, 바람직하게는 물 및 C1-C4의 저급 알코올의 혼합물일 수 있고, 더욱 바람직하게는 물 및 에탄올의 혼합물일 수 있다.When obtaining the extract from the ginseng, at least one selected from the group consisting of water, an organic solvent, a supercritical fluid, and a mixture thereof may be used as an extraction solvent. The organic solvent is an alcohol, preferably a C1-C4 lower alcohol, hexane (n-hexane), ether, glycerol, propylene glycol, butylene glycol, ethyl acetate, methyl acetate, dichloromethane, chloroform, ethyl acetate, benzene and It may be any one selected from the group consisting of these mixed solvents, preferably water. When a mixture of water and an organic solvent is used as the extraction solvent, it may be preferably a mixture of water and a C1-C4 lower alcohol, and more preferably a mixture of water and ethanol.
또한, 인삼 추출물 제조시, 추출은 50℃ 내지 100℃에서 실시될 수 있고, 바람직하게는 70℃ 내지 100℃에서 실시될 수 있으며, 더욱 바람직하게는 90℃ 내지 100℃에서 실시될 수 있으나, 이에 한정되지 아니한다. 추출은 2시간 내지 12시간 동안 실시될 수 있고, 바람직하게는 2시간 내지 10시간 동안 실시될 수 있으며, 더욱 바람직하게는 2시간 내지 8시간 동안 실시될 수 있으나, 이에 한정되지 아니한다. 추출은 1회 내지 8회 실시될 수 있고, 바람직하게는 1회 내지 6회 실시될 수 있으며, 더욱 바람직하게는 1회 내지 4회 실시될 수 있으나, 이에 한정하지 않는다.In addition, when preparing the ginseng extract, the extraction may be carried out at 50 ° C. to 100 ° C., preferably at 70 ° C. to 100 ° C., more preferably at 90 ° C. to 100 ° C. Not limited. The extraction may be carried out for 2 hours to 12 hours, preferably for 2 hours to 10 hours, and more preferably for 2 hours to 8 hours, but is not limited thereto. The extraction may be performed 1 to 8 times, preferably 1 to 6 times, and more preferably 1 to 4 times, but is not limited thereto.
본 발명에서 아교는 소, 말, 당나귀 등의 동물 유래의 가죽이나 뼈를 원료로 하여 물로 가열한 후 추출하고 지방을 제거하고 농축 및 건조시켜 생성되는 것으로서, 바람직하게는 약재로 사용되는 당나귀 유래의 아교(Colla Corii Asini)를 의미한다.In the present invention, glue is produced by heating leather or bones derived from animals such as cattle, horses, and donkeys as raw materials, heating them with water, removing fat, concentrating and drying, and preferably derived from donkeys used as medicines. Glue (Colla Corii Asini).
본 발명의 아교는 통상의 시판되는 아교 블록이거나, 또는 통상의 방식에 의해 당나귀의 가죽이나 뼈에 용매를 가하고 추출한 후 농축 및 건조시켜 형성된 추출물일 수 있다. 상기 추출물을 제조하는 구체적인 공정 조건은 통상의 방식에 의할 수 있다. The glue of the present invention may be a conventional commercially available glue block, or an extract formed by adding a solvent to the hide or bone of a donkey by a conventional method and extracting it, then concentrating and drying it. Specific process conditions for preparing the extract may be in a conventional manner.
상기 당나귀 가죽이나 뼈로부터 추출물을 수득할 때, 물, 유기용매, 초임계 유체 및 이들의 혼합물로 이루어진 군으로부터 선택되는 1종 이상을 추출용매로 사용할 수 있다. 상기 유기용매는 알코올, 바람직하게는 C1-C4의 저급 알코올, 헥산(n-헥산), 에테르, 글리세롤, 프로필렌글리콜, 부틸렌글리콜, 에틸아세테이트, 메틸아세테이트, 디클로로메탄, 클로로포름, 에틸아세테이트, 벤젠 및 이들의 혼합용매로 이루어지는 군으로부터 선택되는 어느 하나일 수 있고, 바람직하게는 물일 수 있다. 물 및 유기용매의 혼합물을 추출 용매로 사용하는 경우, 바람직하게는 물 및 C1-C4의 저급 알코올의 혼합물일 수 있고, 더욱 바람직하게는 물 및 에탄올의 혼합물일 수 있다.When obtaining the extract from the donkey hide or bone, at least one selected from the group consisting of water, an organic solvent, a supercritical fluid, and a mixture thereof may be used as an extraction solvent. The organic solvent is an alcohol, preferably a C1-C4 lower alcohol, hexane (n-hexane), ether, glycerol, propylene glycol, butylene glycol, ethyl acetate, methyl acetate, dichloromethane, chloroform, ethyl acetate, benzene and It may be any one selected from the group consisting of these mixed solvents, preferably water. When a mixture of water and an organic solvent is used as the extraction solvent, it may be preferably a mixture of water and a C1-C4 lower alcohol, and more preferably a mixture of water and ethanol.
또한, 추출 온도는 70℃ 내지 120℃에서 실시될 수 있고, 바람직하게는 80℃ 내지 120℃에서 실시될 수 있으며, 더욱 바람직하게는 90℃ 내지 120℃에서 실시될 수 있으나, 이에 한정되지 아니한다. 추출은 2시간 내지 12시간 동안 실시될 수 있고, 바람직하게는 2시간 내지 8시간 동안 실시될 수 있으며, 더욱 바람직하게는 2시간 내지 4시간 동안 실시될 수 있으나, 이에 한정되지 아니한다. 추출은 1회 내지 4회 실시될 수 있고, 바람직하게는 1회 내지 3회 실시될 수 있으며, 더욱 바람직하게는 1회 내지 2회 실시 될 수 있으나, 이에 한정되지 아니한다. 상기 추출물의 건조는 0~25℃, 또는 0~15℃에서 수행될 수 있으며, 8~15시간, 또는 10~12시간 동안 수행될 수 있다. In addition, the extraction temperature may be carried out at 70 °C to 120 °C, preferably at 80 °C to 120 °C, more preferably at 90 °C to 120 °C, but is not limited thereto. The extraction may be carried out for 2 hours to 12 hours, preferably for 2 hours to 8 hours, and more preferably for 2 hours to 4 hours, but is not limited thereto. The extraction may be performed 1 to 4 times, preferably 1 to 3 times, and more preferably 1 to 2 times, but is not limited thereto. Drying of the extract may be carried out at 0 ~ 25 ℃, or 0 ~ 15 ℃, it may be carried out for 8 ~ 15 hours, or 10 ~ 12 hours.
본 발명의 식품 조성물은 인삼 추출물 50 중량부에 대해서 아교를 35 내지 65 중량부로 포함하거나, 인삼 추출물 50 중량부에 대해서 아교를 37 내지 63 중량부로 포함하거나, 인삼 추출물 50 중량부에 대해서 아교를 40 내지 60 중량부로 포함하거나, 인삼 추출물 50 중량부에 대해서 아교를 42 내지 58 중량부로 포함하거나, 인삼 추출물 50 중량부에 대해서 아교를 45 내지 55 중량부로 포함하거나, 또는 인삼 추출물 50 중량부에 대해서 아교를 47 내지 53 중량부로 포함할 수 있다. 상기 수치범위를 충족하는 경우 피부의 콜라겐 합성능이 더욱 개선됨에 따라 피부의 탄력 또는 보습 개선 효과가 우수할 수 있으며, 특히 인삼 추출물 50 중량부를 기준으로 아교 50 중량부가 포함되는 경우에 특히 우수한 피부의 탄력 또는 보습 개선 효과를 나타낼 수 있다.The food composition of the present invention contains 35 to 65 parts by weight of glue with respect to 50 parts by weight of the ginseng extract, 37 to 63 parts by weight of the glue with respect to 50 parts by weight of the ginseng extract, or 40 parts by weight of the glue with respect to 50 parts by weight of the ginseng extract to 60 parts by weight, or 42 to 58 parts by weight of the glue with respect to 50 parts by weight of the ginseng extract, or 45 to 55 parts by weight of the glue with respect to 50 parts by weight of the ginseng extract, or the glue with respect to 50 parts by weight of the ginseng extract may be included in an amount of 47 to 53 parts by weight. When the above numerical range is satisfied, the skin's elasticity or moisture improvement effect may be excellent as collagen synthesis ability of the skin is further improved. In particular, when 50 parts by weight of glue is included based on 50 parts by weight of ginseng extract, excellent skin elasticity Or it may exhibit a moisturizing improvement effect.
상기 식품 조성물은 본 발명의 인삼 추출물 및 아교 외에 본 발명이 목적으로 하는 효과를 손상시키지 않는 범위 내에서, 바람직하게는 상기 인삼 추출물 및 아교의 효과에 상승 효과를 줄 수 있는 다른 성분 등을 추가로 함유할 수 있다. 예를 들어 안정화제, 용해화제, 비타민 등과 같은 통상적인 보조제, 또는 담체를 포함할 수 있다.The food composition is a ginseng extract and glue of the present invention In addition, within the range that does not impair the effect of the present invention, it may further contain, preferably, other ingredients that can give a synergistic effect to the effect of the ginseng extract and the glue. For example, it may contain conventional adjuvants such as stabilizers, solubilizers, vitamins and the like, or carriers.
또한 식품 제조시 통상적으로 첨가되는 성분을 포함할 수 있으며, 예를 들어, 단백질, 탄수화물, 지방, 영양소, 조미제 및 향미제를 포함한다. 상기 탄수화물의 예는 모노사카라이드, 예를 들어, 포도당, 과당 등; 디사카라이드, 예를 들어 말토스, 슈크로스, 올리고당 등; 및 폴리사카라이드, 예를 들어 덱스트린, 사이클로덱스트린 등과 같은 통상적인 당 및 자일리톨, 소르비톨, 에리트리톨 등의 당알콜이다. 상기 향미제로는 천연 향미제 타우마틴, 스테비아 추출물 및 합성 향미제를 사용할 수 있다. 예컨대, 본 발명의 식품 조성물이 드링크제로 제조되는 경우에는 본 발명의 인삼 추출물 및 아교 이외에 구연산, 액상과당, 설탕, 포도당, 초산, 사과산, 과즙, 천연 추출액 등이 추가로 포함될 수 있다.In addition, it may include ingredients commonly added during food production, for example, proteins, carbohydrates, fats, nutrients, seasonings and flavoring agents. Examples of the carbohydrate include monosaccharides such as glucose, fructose and the like; disaccharides such as maltose, sucrose, oligosaccharides and the like; and polysaccharides, for example, conventional sugars such as dextrin, cyclodextrin, and the like, and sugar alcohols such as xylitol, sorbitol, and erythritol. As the flavoring agent, a natural flavoring agent taumatin, a stevia extract, and a synthetic flavoring agent may be used. For example, when the food composition of the present invention is prepared as a drink, citric acid, high fructose, sugar, glucose, acetic acid, malic acid, fruit juice, natural extract, etc. may be additionally included in addition to the ginseng extract and glue of the present invention.
상기 식품 조성물을 활용한 식품의 종류에는 특별한 제한은 없다. 본 발명의 인삼 추출물 및 아교를 포함하는 식품 조성물을 첨가할 수 있는 식품의 예로는 육류, 소세지, 빵, 쵸코렛, 캔디류, 스낵류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차, 드링크제, 알콜 음료 및 비타민 복합제 등이 있으며, 통상적인 의미에서의 식품을 모두 포함한다.There is no particular limitation on the type of food using the food composition. Examples of foods to which the food composition containing the ginseng extract and glue of the present invention can be added include meat, sausage, bread, chocolate, candy, snacks, confectionery, pizza, ramen, other noodles, gums, dairy products including ice cream , various soups, beverages, teas, drinks, alcoholic beverages, and vitamin complexes, and includes all foods in a conventional sense.
상기 식품은 피부의 탄력 또는 보습 개선을 목적으로, 정제, 캅셀, 분말, 과립, 액상, 환 등의 형태로 제조 및 가공할 수 있다.The food can be manufactured and processed in the form of tablets, capsules, powders, granules, liquids, pills, etc. for the purpose of improving skin elasticity or moisture.
예를 들어, 정제 형태의 식품은 상기 식품 조성물을 부형제, 결합제, 붕해제 및 다른 첨가제와 혼합한 혼합물을 통상의 방법으로 과립화한 다음, 활택제 등을 넣어 압축성형하거나, 상기 혼합물을 직접 압축 성형할 수 있다. 또한 상기 정제 형태의 식품은 필요에 따라 교미제 등을 함유할 수도 있다.For example, food in tablet form is granulated by a mixture obtained by mixing the food composition with excipients, binders, disintegrants and other additives in a conventional manner, followed by compression molding by adding a lubricant or the like, or by directly compressing the mixture. can be molded. In addition, the food in the form of tablets may contain a corrosive agent or the like, if necessary.
캅셀 형태의 식품 중 경질 캅셀제는 통상의 경질 캅셀에 상기 식품 조성물을 부형제 등의 첨가제와 혼합한 혼합물을 충진하여 제조할 수 있으며, 연질 캅셀제는 상기 식품 조성물을 부형제 등의 첨가제와 혼합한 혼합물을 젤라틴과 같은 캅셀기제에 충진하여 제조할 수 있다. 상기 연질 캅셀제는 필요에 따라 글리세린 또는 소르비톨 등의 가소제, 착색제, 보존제 등을 함유할 수 있다.Hard capsules among foods in capsule form can be prepared by filling a mixture of the food composition with additives such as excipients in conventional hard capsules, and soft capsules are gelatin obtained by mixing the food composition with additives such as excipients. It can be prepared by filling in a capsule base such as The soft capsules may contain a plasticizer such as glycerin or sorbitol, a colorant, a preservative, and the like, if necessary.
환 형태의 식품은 상기 식품 조성물과 부형제, 결합제, 붕해제 등을 혼합한 혼합물을 기존에 공지된 방법으로 성형하여 조제할 수 있으며, 필요에 따라 백당이나 다른 제피제로 제피할 수 있으며, 또는 전분, 탈크와 같은 물질로 표면을 코팅할 수도 있다.Food in the form of a ring can be prepared by molding a mixture in which the food composition and excipients, binders, disintegrants, etc. are mixed by a known method, and if necessary, can be coated with sucrose or other skinning agent, or starch, It is also possible to coat the surface with a material such as talc.
과립 형태의 식품은 상기 식품 조성물과 부형제, 결합제, 붕해제 등을 혼합한 혼합물을 기존에 공지된 방법으로 입상으로 제조할 수 있으며, 필요에 따라 착향제, 교미제 등을 함유할 수 있다.Food in the form of granules may be prepared in a granular form by a conventionally known method by mixing a mixture of the food composition with an excipient, binder, disintegrant, etc., and may contain a flavoring agent, a flavoring agent, etc. as necessary.
2. 피부의 탄력 또는 보습 개선용 약학적 조성물2. Pharmaceutical composition for improving skin elasticity or moisture
본 발명의 일 양태는 인삼 추출물; 및 아교;를 유효성분으로 포함하는 피부의 탄력 또는 보습 개선용 약학적 조성물을 제공한다. One aspect of the present invention is a ginseng extract; And glue; provides a pharmaceutical composition for improving skin elasticity or moisture, comprising as an active ingredient.
본 발명의 약학적 조성물은 인삼 추출물 50 중량부에 대해서 아교를 35 내지 65 중량부로 포함하거나, 인삼 추출물 50 중량부에 대해서 아교를 37 내지 63 중량부로 포함하거나, 인삼 추출물 50 중량부에 대해서 아교를 40 내지 60 중량부로 포함하거나, 인삼 추출물 50 중량부에 대해서 아교를 42 내지 58 중량부로 포함하거나, 인삼 추출물 50 중량부에 대해서 아교를 45 내지 55 중량부로 포함하거나, 또는 인삼 추출물 50 중량부에 대해서 아교를 47 내지 53 중량부로 포함할 수 있다. 상기 수치범위를 충족하는 경우, 피부의 콜라겐 합성능이 더욱 개선됨에 따라 피부 탄력 또는 보습 개선 효과가 우수할 수 있으며, 특히 인삼 추출물 50 중량부를 기준으로 아교 50 중량부가 포함되는 경우에 특히 우수한 피부의 탄력 또는 보습 개선 효과를 나타낼 수 있다.The pharmaceutical composition of the present invention comprises 35 to 65 parts by weight of glue based on 50 parts by weight of the ginseng extract, 37 to 63 parts by weight of the glue with respect to 50 parts by weight of the ginseng extract, or 50 parts by weight of the ginseng extract. 40 to 60 parts by weight, or 42 to 58 parts by weight of glue with respect to 50 parts by weight of ginseng extract, 45 to 55 parts by weight of glue with respect to 50 parts by weight of ginseng extract, or 50 parts by weight of ginseng extract Glue may be included in an amount of 47 to 53 parts by weight. When the above numerical range is satisfied, the skin elasticity or moisture improvement effect may be excellent as the collagen synthesis ability of the skin is further improved. Or it may exhibit a moisturizing improvement effect.
본 발명의 약학적 조성물은 상기 인삼 추출물 및 아교 외에 본 발명이 목적으로 하는 효과를 손상시키지 않는 범위 내에서, 바람직하게는 상기 인삼 추출물 및 아교의 효과에 상승 효과를 줄 수 있는 다른 성분 등을 추가로 함유할 수 있다. 예를 들어 항산화제, 안정화제, 용해화제, 비타민과 같은 통상적인 보조제, 또는 담체를 포함할 수 있다.In addition to the ginseng extract and the glue, the pharmaceutical composition of the present invention preferably adds other ingredients that can give a synergistic effect to the effect of the ginseng extract and the glue within a range that does not impair the effect of the present invention. may contain. For example, antioxidants, stabilizers, solubilizers, conventional adjuvants such as vitamins, or carriers may be included.
상기 약학적 조성물의 투여 경로는 구강을 통하여야 한다. The route of administration of the pharmaceutical composition should be through the oral cavity.
본 발명의 약학적 조성물은 약학적으로 유효한 양으로 투여할 수 있다.The pharmaceutical composition of the present invention may be administered in a pharmaceutically effective amount.
본 발명에서 "약학적으로 유효한 양"은 의학적 치료에 적용 가능한 합리적인 수혜/위험 비율로 질환을 치료하기에 충분한 양을 의미하며, 유효 용량 수준은 개체 종류 및 중증도, 연령, 성별, 질병의 종류, 약물의 활성, 약물에 대한 민감도, 투여 시간, 투여 경로 및 배출 비율, 치료 기간, 동시 사용되는 약물을 포함한 요소 및 기타 의학 분야에 잘 알려진 요소에 따라 결정될 수 있다. 본 발명의 조성물은 개별 치료제로 투여하거나 다른 치료제와 병용하여 투여될 수 있고 종래의 치료제와는 순차적 또는 동시에 투여될 수 있다. 그리고 단일 또는 다중 투여될 수 있다. 상기 요소를 모두 고려하여 부작용 없이 최소한의 양으로 최대 효과를 얻을 수 있는 양을 투여하는 것이 중요하며, 본 기술분야의 통상의 기술자에 의해 용이하게 결정될 수 있다.In the present invention, "pharmaceutically effective amount" means an amount sufficient to treat a disease at a reasonable benefit/risk ratio applicable to medical treatment, and the effective dose level includes the subject type and severity, age, sex, type of disease, The activity of the drug, the sensitivity to the drug, the time of administration, the route of administration and the rate of excretion, the duration of treatment, factors including concurrent drugs, and other factors well known in the medical field can be determined according to factors. The composition of the present invention may be administered as an individual therapeutic agent or in combination with other therapeutic agents, and may be administered sequentially or simultaneously with conventional therapeutic agents. and may be administered single or multiple. Taking all of the above factors into consideration, it is important to administer an amount that can obtain the maximum effect with a minimum amount without side effects, and can be easily determined by a person skilled in the art.
본 발명의 약학적 조성물은 피부의 탄력 개선 또는 보습을 목적으로 하는 개체이면 특별히 한정되지 않고, 어떠한 것이든 적용 가능하다. 예를 들면, 본 발명의 약학적 조성물은 인간뿐만 아니라 원숭이, 개, 고양이, 토끼, 모르모트, 랫트, 마우스, 소, 양, 돼지, 염소 등과 같은 인간이 아닌 동물, 조류 및 어류 등 어느 것에 사용 가능하다.The pharmaceutical composition of the present invention is not particularly limited as long as it is an individual for the purpose of improving skin elasticity or moisturizing, and any one is applicable. For example, the pharmaceutical composition of the present invention can be used not only for humans but also for non-human animals such as monkeys, dogs, cats, rabbits, guinea pigs, rats, mice, cattle, sheep, pigs, goats, etc., birds and fish. do.
상기 약학적 조성물은 상기 인삼 추출물 및 아교에 추가로 동일 또는 유사한 기능을 나타내는 유효성분을 1종 이상 함유할 수 있다. 상기 약학적 조성물은 각각 통상의 방법에 따라 산제, 과립제, 정제, 캡슐제, 현탁액, 에멀젼, 시럽 등의 경구형 제형으로 제형화하여 사용될 수 있다.The pharmaceutical composition may contain one or more active ingredients exhibiting the same or similar functions in addition to the ginseng extract and glue. The pharmaceutical composition may be formulated and used in oral dosage forms such as powders, granules, tablets, capsules, suspensions, emulsions, syrups, and the like according to a conventional method, respectively.
경구 투여를 위한 고형 제제에는 산제, 과립제, 정제, 캡슐제, 연질 캅셀제, 환 등이 포함된다. 경구투여를 위한 액상 제제로는 현탁제, 내용액제, 유제, 시럽제 등이 해당되는데 흔히 사용되는 단순 희석제인 물, 리퀴드 파라핀 이외에 여러 가지 부형제, 예를 들면 습윤제, 감미제, 방향제, 보존제 등이 포함될 수 있다. Solid preparations for oral administration include powders, granules, tablets, capsules, soft capsules, pills, and the like. Liquid formulations for oral administration include suspensions, solutions, emulsions, syrups, etc. In addition to commonly used simple diluents such as water and liquid paraffin, various excipients such as wetting agents, sweeteners, fragrances, and preservatives may be included. have.
상기 약학적 조성물은 방부제, 안정화제, 수화제 또는 유화 촉진제, 삼투압 조절을 위한 염 및/또는 완충제 등의 보조제, 및 기타 치료적으로 유용한 물질을 추가로 함유할 수 있으며, 통상적인 방법인 혼합, 과립화 또는 코팅 방법에 따라 제형화할 수 있다.The pharmaceutical composition may further contain adjuvants such as preservatives, stabilizers, wetting agents or emulsification accelerators, salts and/or buffers for regulating osmotic pressure, and other therapeutically useful substances, and mixing, granulation, which is a conventional method It can be formulated according to the method of formulation or coating.
상기 약학적 조성물의 투여량은 개체의 연령, 체중, 일반적인 건강, 성별, 투여시간, 투여 경로, 배출률, 약물 배합 및 특정 질환의 중증을 포함한 여러 요인에 따라 다양하게 변할 수 있다. The dosage of the pharmaceutical composition may vary according to various factors including the age, weight, general health, sex, administration time, administration route, excretion rate, drug formulation, and severity of a specific disease of the individual.
또한, 본 발명의 약학적 조성물은 단독으로, 또는 수술, 방사선 치료, 호르몬 치료, 화학 치료 및 생물학적 반응 조절제를 사용하는 방법들과 병용하여 사용할 수 있다. 또한 상기 약학적 조성물은 성인 기준으로 0.001 내지 200 ㎎/㎏ 범위 내의 투여량으로 투여될 수 있으나, 상기 투여량은 본 발명의 범위를 한정하는 것이 아니다.In addition, the pharmaceutical composition of the present invention can be used alone or in combination with methods using surgery, radiation therapy, hormone therapy, chemotherapy, and biological response modifiers. In addition, the pharmaceutical composition may be administered in a dosage within the range of 0.001 to 200 mg/kg based on an adult, but the dosage is not limited to the scope of the present invention.
이하, 본 발명을 실시예에 의해 상세히 설명한다.Hereinafter, the present invention will be described in detail by way of Examples.
단, 하기 실시예는 본 발명을 예시하기 위한 것일 뿐, 본 발명의 내용이 하기 실시예에 의해 한정되는 것은 아니다.However, the following examples are only for illustrating the present invention, and the content of the present invention is not limited by the following examples.
<제조예 1> 홍삼 농축액의 제조 <Preparation Example 1> Preparation of red ginseng concentrate
홍삼 20kg에 정제수 8~12배수를 가하여 90±10℃에서 8시간씩 4회 추출한 다음 저온에서 원심분리 후 감압 농축하여 홍삼농축액 14kg을 수득하였다.After adding 8 to 12 times of purified water to 20 kg of red ginseng, it was extracted 4 times at 90±10° C. for 8 hours, and then centrifuged at low temperature and concentrated under reduced pressure to obtain 14 kg of red ginseng concentrate.
<제조예 2> 아교의 제조<Production Example 2> Preparation of glue
당나귀 껍질 20kg에 정제수 8~12배수를 가하여 90±10℃에서 4시간씩 3회 추출한 다음 저온에서 원심분리 후 감압 농축 및 건조하여 아교 8kg을 수득하였다.8-12 times of purified water was added to 20 kg of donkey skin, extracted three times at 90±10° C. for 4 hours, and then centrifuged at low temperature, concentrated and dried under reduced pressure to obtain 8 kg of glue.
<제조예 3> 홍삼 농축액 및 아교의 복합물의 제조<Preparation Example 3> Preparation of a complex of red ginseng concentrate and glue
제조예 1 및 제조예 2에서 얻어진 단독 추출물을 비율을 다르게 하여 홍삼 농축액과 아교의 혼합물을 제조하였다. 홍삼 농축액 및 아교의 함량을 100㎍/㎖:100㎍/㎖, 100㎍/㎖:50㎍/㎖, 50㎍/㎖:100㎍/㎖로 하여 3종류의 혼합물을 제조하였다.A mixture of red ginseng concentrate and glue was prepared by varying the ratio of the single extract obtained in Preparation Examples 1 and 2 prepared. Three types of mixtures were prepared by adjusting the red ginseng concentrate and the amount of glue to 100 µg/ml: 100 µg/ml, 100 µg/ml: 50 µg/ml, and 50 µg/ml: 100 µg/ml.
<실시예 1> 프로콜라겐 합성능 확인<Example 1> Confirmation of procollagen synthesis ability
<1-1> 실험방법<1-1> Experimental method
피부섬유아세포(fibroblast) (ATCC, USA)를 24웰 플레이트에 1×105씩 분주한 후 DMEM:F12 혼합배지에 10% 소혈청을 함유시킨 후 37℃, 5% CO2 배양기에서 배양하였다. 24시간이 지난 후, 제조예 1의 홍삼 농축액 및 제조예 2의 아교를 단독으로 각각 50 ㎍/㎖ 또는 100 ㎍/㎖ 농도로 처리하고, 제조예 3의 홍삼 농축액 및 아교의 복합물을 처리하였으며, 양성대조군으로는 L-아스코르브산(L-ascorbic acid)을 20 ㎍/㎖ 농도로 처리하였다. 시료 처리 24시간 후 상층액만을 분리하여 상층액 내의 프로콜라겐형(I) ELISA 키트(procollagen type(I)) (Takara, Japan)를 이용하여 프로콜라겐(procollagen)의 증감 여부를 관찰하였다. Skin fibroblasts (ATCC, USA) were aliquoted at 1×10 5 in a 24-well plate, and 10% bovine serum was added to a DMEM:F12 mixed medium and cultured at 37° C., 5% CO 2 incubator. After 24 hours, the red ginseng concentrate of Preparation Example 1 and the glue of Preparation Example 2 were treated alone at a concentration of 50 μg/ml or 100 μg/ml, respectively, and the complex of the red ginseng concentrate of Preparation Example 3 and the glue was treated, As a positive control group, L-ascorbic acid was treated at a concentration of 20 μg/ml. After 24 hours of sample treatment, only the supernatant was separated, and the increase or decrease of procollagen in the supernatant was observed using a procollagen type (I) ELISA kit (Takara, Japan) in the supernatant.
무처리 대조군(Control) 대비 프로콜라겐 I형 합성 증가량(%)을 계산하되, 모든 값은 2회 반복 측정 후 평균±표준편차로 작성하였으며, 그 결과를 도 1에 나타낸다. The increase (%) of procollagen type I synthesis compared to the untreated control group was calculated, but all values were prepared as the mean±standard deviation after repeated measurement twice, and the results are shown in FIG. 1 .
<1-2> 프로콜라겐 합성능<1-2> Procollagen synthesis ability
도 1로부터, 홍삼 농축액 및 아교의 복합물의 경우 아교를 단독으로 처리한 경우에 비해 프로콜라겐 합성능이 우수하고, 특히 홍삼 농축액 100 ㎍/㎖ 및 아교 100 ㎍/㎖를 혼합하여, 즉 1:1의 중량비로, 사용한 경우에 가장 우수한 프로콜라겐 합성 효과를 나타내는 것을 확인할 수 있다.From Figure 1, in the case of the red ginseng concentrate and the glue, the procollagen synthesizing ability is superior compared to the case of the glue alone treatment. By weight, it can be confirmed that the most excellent procollagen synthesis effect when used.
<제조예 4> 홍삼 농축액 및 아교를 포함하는 식품 조성물의 제조<Preparation Example 4> Preparation of food composition comprising red ginseng concentrate and glue
벌꿀(허니스티, 프리미엄 아카시아꿀) 120g, 식물혼합농축액(KGC예본, 식물혼합농축액1120) 30g, 말토올리고당(인그리디언코리아, MO-R1) 490g을 교반하며 가온(80~100℃) 혼합하여 제1 혼합물을 형성하였다. Honey (Honey Tea, Premium Acacia Honey) 120g, Plant Mixture Concentrate (KGC Yebon, Plant Mixture Concentrate 1120) 30g, Maltooligosaccharide (Ingredion Korea, MO-R1) 490g Heat (80~100℃) and mix with stirring. A first mixture was formed.
제조예 2의 아교 100g을 상온의 정제수 100g에 투입하고 교반하여 용해시킨 후, 본 아교 용해액을 상기 제1 혼합물에 투입하고 교반하여 제2 혼합물을 형성하였다. After adding 100 g of the glue of Preparation Example 2 to 100 g of purified water at room temperature and stirring to dissolve it, the present glue solution was added to the first mixture and stirred to form a second mixture.
상기 제2 혼합물에 제조예 1의 홍삼농축액 100g, 정제수 60g을 투입하고 혼합하여 점조성의 액상 조성물을 제조하였다. 100 g of the red ginseng concentrate of Preparation Example 1 and 60 g of purified water were added to the second mixture and mixed to prepare a viscous liquid composition.
<실시예 2> 피부 보습력 개선 효과<Example 2> Skin moisturizing effect improvement effect
<2-1> 실험방법<2-1> Experimental method
제조예 4의 식품 조성물의 섭취 후 피부 보습력 개선 효과를 검증하기 위해 40~50대의 성인 남녀 각 6명(총 12명)에게 8주 동안 매일 1회 상기 식품 조성물을 섭취하도록 하였다. In order to verify the skin moisturizing effect after ingestion of the food composition of Preparation Example 4, 6 adult men and women in their 40s to 50s (12 in total) were allowed to ingest the food composition once daily for 8 weeks.
제품 복용 전 피험자의 전완부를 흐르는 물로 세정하고 항온항습 조건(20~24℃, 40~60% RH) 에서 피부의 수분량을 코르네오미터(Corneometer) CM825로 측정하였다. 이후 피험자들에게 제품을 섭취하도록 하면서 섭취 4주 후, 섭취 8주 후에 동일한 방법으로 피부의 수분량을 코르네오미터 CM825로 측정하였다. 측정은 5회 반복하여 최대값과 최소값을 제거한 3회 측정값의 평균을 나타내었고, 통계분석은 IBM SPSS 통계도구(USA)를 이용하여 윌콕슨 부호순위 검정법으로 분석하였다. 그 결과를 도 2에 나타낸다. Before taking the product, the subject's forearm was washed with running water, and the moisture content of the skin was measured with a Corneometer CM825 under constant temperature and humidity conditions (20~24℃, 40~60% RH). After 4 weeks of ingestion and 8 weeks after ingestion, subjects were asked to ingest the product, and the moisture content of the skin was measured with a corneometer CM825 in the same manner. The measurement was repeated 5 times, and the average of the three measurements with the maximum and minimum values removed was shown, and statistical analysis was performed using the Wilcoxon signed rank test using IBM SPSS statistical tool (USA). The results are shown in FIG. 2 .
<2-2> 피부 수화도<2-2> Skin hydration
도 2로부터, 본 발명의 식품 조성물을 섭취함으로써 피부 보습력이 개선되는 것을 확인할 수 있다. 구체적으로, 본 발명의 식품 조성물을 8주 동안 섭취한 후에 피부 수화도가 유의적으로 개선된 것을 알 수 있다.From Figure 2, it can be confirmed that the skin moisturizing power is improved by ingesting the food composition of the present invention. Specifically, it can be seen that the degree of skin hydration is significantly improved after ingesting the food composition of the present invention for 8 weeks.
<실시예 3> 피부 탄력 개선 효과<Example 3> Skin elasticity improvement effect
<3-1> 실험방법<3-1> Experimental method
제조예 4의 식품 조성물의 섭취 후 피부 탄력 개선 효과를 검증하기 위해 40~50대의 성인 남녀 각 6명(총 12명)에게 8주 동안 매일 1회 상기 식품 조성물을 섭취하도록 하였다. In order to verify the skin elasticity improvement effect after ingestion of the food composition of Preparation Example 4, 6 adult men and women in their 40s to 50s (12 in total) were allowed to ingest the food composition once daily for 8 weeks.
제품 복용 전 피험자의 전완부를 흐르는 물로 세정하고 항온항습 조건(20~24℃, 40~60% RH) 에서 피부의 탄력을 큐토미터(Cutometer) MPA580으로 측정하였다. 이후 피험자들에게 제품을 섭취하도록 하면서 섭취 4주 후, 섭취 8주 후에 동일한 방법으로 피부의 탄력을 큐토미터 MPA580로 측정하였다. 측정은 3회 반복하여 평균을 나타내었고, 통계분석은 IBM SPSS 통계도구(USA)를 이용하여 윌콕슨 부호순위 검정법으로 분석하였다. 그 결과를 도 3에 나타낸다.Before taking the product, the subject's forearm was washed with running water, and skin elasticity was measured with a Cutometer MPA580 under constant temperature and humidity conditions (20~24℃, 40~60% RH). After 4 weeks of ingestion and 8 weeks after ingestion, subjects were asked to ingest the product, and skin elasticity was measured with a cutometer MPA580 in the same manner. Measurements were repeated three times to represent the average, and statistical analysis was performed using the Wilcoxon signed rank test using IBM SPSS statistical tool (USA). The results are shown in FIG. 3 .
<3-2> 피부 탄력<3-2> Skin elasticity
도 3으로부터, 본 발명의 식품 조성물을 섭취함으로써 피부 탄력이 개선되는 것을 확인할 수 있다. 구체적으로, 본 발명의 식품 조성물을 8주 동안 섭취한 후에 피부 탄력이 유의적으로 개선된 것을 알 수 있다.From FIG. 3, it can be confirmed that skin elasticity is improved by ingesting the food composition of the present invention. Specifically, it can be seen that skin elasticity is significantly improved after ingesting the food composition of the present invention for 8 weeks.
<제조예 5> 음료의 제조<Preparation Example 5> Preparation of beverage
<5-1> 건강음료의 제조<5-1> Manufacturing of health drinks
액상과당(0.5%), 올리고당(2%), 설탕(2%), 식염(0.5%), 물(75%)과 같은 부재료와 본 발명의 홍삼 농축액 및 아교의 혼합물(중량비 1:1) 5 g을 균질하게 배합하여 순간 살균을 한 후 이를 유리병, 패트병 등 소포장 용기에 포장하여 제조하였다.Mixture of the red ginseng concentrate and glue of the present invention with auxiliary materials such as high fructose (0.5%), oligosaccharide (2%), sugar (2%), salt (0.5%), and water (75%) 5 g was homogeneously mixed and instantaneously sterilized, and then packaged in small packaging containers such as glass bottles and plastic bottles.
<5-2> 야채 주스의 제조<5-2> Preparation of vegetable juice
본 발명의 홍삼 농축액 및 아교의 혼합물(중량비 1:1) 5 g을 토마토 또는 당근 주스 1,000 ㎖에 가하여 야채 주스를 제조하였다.Vegetable juice was prepared by adding 5 g of a mixture of red ginseng concentrate and glue of the present invention (weight ratio 1:1) to 1,000 ml of tomato or carrot juice.
<5-3> 과일 주스의 제조<5-3> Preparation of fruit juice
본 발명의 홍삼 농축액 및 아교의 혼합물(중량비 1:1) 1 g을 사과 또는 포도 주스 1,000 ㎖ 에 가하여 과일 주스를 제조하였다. Fruit juice was prepared by adding 1 g of a mixture of red ginseng concentrate of the present invention and glue (weight ratio 1:1) to 1,000 ml of apple or grape juice.
Claims (7)
인삼 추출물 50 중량부에 대해서 아교 40 내지 60 중량부를 포함하는 식품 조성물.The method according to claim 1,
A food composition comprising 40 to 60 parts by weight of a glue based on 50 parts by weight of the ginseng extract.
인삼 추출물 50 중량부에 대해서 아교 45 내지 55 중량부를 포함하는 식품 조성물.The method according to claim 1,
A food composition comprising 45 to 55 parts by weight of a glue based on 50 parts by weight of the ginseng extract.
인삼 추출물 50 중량부에 대해서 아교 47 내지 53 중량부를 포함하는 식품 조성물.The method according to claim 1,
A food composition comprising 47 to 53 parts by weight of a glue based on 50 parts by weight of the ginseng extract.
상기 인삼 추출물은 인삼에 물을 가하고 50~100℃에서 2~12시간 동안 추출하여 수득되는 식품 조성물.The method according to claim 1,
The ginseng extract is a food composition obtained by adding water to ginseng and extracting it at 50 to 100° C. for 2 to 12 hours.
상기 아교는 당나귀 유래의 아교인 식품 조성물.The method according to claim 1,
The glue is a donkey-derived food composition.
음료수, 차, 드링크제, 알콜 음료 및 비타민 복합제로 이루어진 군으로부터 선택되는 식품 조성물.The method according to claim 1,
A food composition selected from the group consisting of beverages, teas, drinks, alcoholic beverages and vitamin complexes.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210011840A KR20220108628A (en) | 2021-01-27 | 2021-01-27 | Food Composition For Improving Skin Elasticity Or Moisture |
KR1020240022012A KR20240029006A (en) | 2021-01-27 | 2024-02-15 | Food Composition For Improving Skin Elasticity Or Moisture |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210011840A KR20220108628A (en) | 2021-01-27 | 2021-01-27 | Food Composition For Improving Skin Elasticity Or Moisture |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020240022012A Division KR20240029006A (en) | 2021-01-27 | 2024-02-15 | Food Composition For Improving Skin Elasticity Or Moisture |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20220108628A true KR20220108628A (en) | 2022-08-03 |
Family
ID=82847325
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210011840A KR20220108628A (en) | 2021-01-27 | 2021-01-27 | Food Composition For Improving Skin Elasticity Or Moisture |
KR1020240022012A KR20240029006A (en) | 2021-01-27 | 2024-02-15 | Food Composition For Improving Skin Elasticity Or Moisture |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020240022012A KR20240029006A (en) | 2021-01-27 | 2024-02-15 | Food Composition For Improving Skin Elasticity Or Moisture |
Country Status (1)
Country | Link |
---|---|
KR (2) | KR20220108628A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101743572B1 (en) | 2017-04-12 | 2017-06-05 | 주식회사 더마랩 | Method for making glue from donkey skin using terra alba and mineral water and cosmetics containing the same |
-
2021
- 2021-01-27 KR KR1020210011840A patent/KR20220108628A/en not_active IP Right Cessation
-
2024
- 2024-02-15 KR KR1020240022012A patent/KR20240029006A/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101743572B1 (en) | 2017-04-12 | 2017-06-05 | 주식회사 더마랩 | Method for making glue from donkey skin using terra alba and mineral water and cosmetics containing the same |
Also Published As
Publication number | Publication date |
---|---|
KR20240029006A (en) | 2024-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101160943B1 (en) | Health functional foods compositions for the prevention and amelioration of cancer containing the mixed extract of Phellinus linteus mycelium and cultured Panax Ginseng Cameyer as an active ingredient | |
US20080261896A1 (en) | Testosterone generating and metabolizing enhancer | |
KR20180010961A (en) | Composition for preventing, treating or improving muscle atrophy comprising complex extracts | |
KR20210108911A (en) | A composition for antioxidant or whitening compriging rosemary ionic liquid extract | |
KR101295368B1 (en) | Composition for skin wrinkle improvement comprising extracts of honeybush extract or its fermentation solution as an active ingredient | |
JPWO2004112817A1 (en) | Celery family-derived extract and method for producing the same | |
KR20170121532A (en) | Composition for relieving menopausal symptom or osteoporosis | |
JP2003055244A (en) | Agent promoting hyaluronic acid production, cosmetics, food and beverage including the hyaluronic acid production-promoting agent | |
KR20160141027A (en) | Phamaceutical composition or healthy food comprising water extracts from Pleurotus eryngii var. ferulea (Pf.). for treating or preventing metabolic disorder | |
JP6765090B2 (en) | Black ginger-containing composition | |
KR102201312B1 (en) | Pharmaceutical Composition Comprising Extracts of Ginseng and Ginseng Berry for Preventing or Treating Muscle Disease | |
KR20200140749A (en) | Composition for improvement, treatment or prevention of muscular disorders, or improvement of muscular functions comprising Cudrania tricuspidata | |
KR101705354B1 (en) | A composition comprising the alcohol extract of Botrychium ternatum for preventing or treating skin inflammation | |
KR101919161B1 (en) | Composition for improving condition of hair and preventing hair loss | |
KR101732483B1 (en) | Composition for prevention, improvement or treatment of peripheral neuropathy comprising Forsythiae Fructus extract as effective component | |
KR20150115414A (en) | The pharmaceutical compositions for prevention or treatment of inflammatory diseases or promotion of wound healing containing ethylacetate fraction of Schizandra chinensis Baillon | |
KR20220108628A (en) | Food Composition For Improving Skin Elasticity Or Moisture | |
KR102234860B1 (en) | Composition for prevention and treatment of muscle atrophy comprising lespedeza bicolor extract | |
KR101579500B1 (en) | Skin whitening composition comprising an extract obtained from roots of coix lachryma-jobi var. mayuen | |
JP7296611B2 (en) | Nitric oxide production accelerator | |
KR20170014329A (en) | A food composition comprising extract of donkey | |
KR20210006192A (en) | Method of Preparing Extract of Red Ginseng Having a Reduced Chromaticity | |
KR102429214B1 (en) | A composition for stimulating growth of hairs contaning natural complex extracts | |
KR102597262B1 (en) | Food composition for Antioxidant or Anti-aging | |
KR101257909B1 (en) | Pharmaceurtical compositions for the prevention or treatment of cancer containing the mixed extract of Phellinus linteus mycelium and cultured Panax Ginseng Cameyer as an active ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
AMND | Amendment | ||
X601 | Decision of rejection after re-examination |